Deal-Ticker: LEM Surgical AG Successfully Completed CHF 22 Million Series B Round to Ready Robotic System for FDA Submission

Berne-based LEM Surgical AG, an innovative company specializing in surgical robotics, has successfully completed its financing round B at the End of December 2023. CHF 22 million in funding have been secured from new investors from both the United States and Switzerland. 

The newly acquired funds will be used to propel the advancement of LEM Surgical's product development initiatives and readiness for FDA submission in the second half of 2024.  

Kellerhals Carrard (Robin Juchler and Beat Brechbühl Co-Leads, Michèle Remund and Quentin Bärtschi) supported LEM Surgical in the transaction. Yossi Bar, CEO: “The KC team provided swift, professional, and goal-oriented advice and support in the whole process. We’re grateful for the solid support and the friendly relationship.” 

Press release: LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission